Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ·Healthcare·Biotechnology
$16.12
-1.53%
Mkt Cap $2.10B
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (9 analysts)
$15.50
Range $15.00 – $16.00
Implied Upside
-3.8%
Consensus $15.50 vs current $16.12
NASDAQ·Healthcare·Biotechnology
$16.12
-1.53%
Mkt Cap $2.10B
Buy
1
Hold
0
Sell
0
Price Target (9 analysts)
$15.50
Range $15.00 – $16.00
-3.8%
Consensus $15.50 vs current $16.12